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Abstract 
Background: Gluten sensitive enteropathy (celiac disease (CD)) has a strong association with 
diabetes mellitus (type 1DM). Since, 2-3% of CD patients have selective IgA deficiency, the 
majority of the available tests may fail to show the auto-antibodies (the IgA endomysial antibody 
(EMA). To prevent such a false negativity, a new Enzyme Linked Immune Sorbent Assay (ELISA) 
test has been introduced to detect both IgG and IgA antibodies reactive with tissue transglutaminase 
(tTG), an autoantigen in CD patients.  
Objectives: This study has been conducted to detect celiac disease among Sudanese patients with 
type 1 autoimmune diabetes using anti-tissue transglutinamase antibodies as a diagnostic tool.  
Patients and Methods: Samples were collected from sixty nine randomly selected patients (38 
males and 31 females) and their age ranged between 3-22 years with DM type 1 who were attending 
the outpatient clinics in Gabir Abu Eliz diabetic Center and Omdurman Pediatric Emergency 
Hospital. Blood samples were collected from 25 healthy individuals as controls. Levels of tTG 
specific IgA, tTG specific IgG and anti-endomysial antibodies of IgA class were measured in sera 
collected from both cases and from controls. All the results were analyzed using Statistical 
Packages of Social Sciences (SPSS) version 17 and MicroSoft office excel.  
Results: Seven out of 69 patients with DM type 1 (10.1%) were identified as having CD using IgG 
anti-tTG and 5 (7.2%) of them were positive for IgA anti-tTG and IgA anti-endomysial antibodies. 
The mean of both anti-tTG IgA and IgG titers were higher in diabetic patients (M±SD = 12.30±41.0 
and 7.2±13.1 respectively) when compared with the control group (M±SD =1.8±1.1 and 1.8±0.9 
respectively), however, only anti-tTG IgG antibodies titer achieved statistical significance. 
Discussion and conclusion: The present study revealed that patients with DM type I have an 
increased tendency to develop CD. The increased association of CD and selective IgA deficiency is 
a potential source of false-negative IgA, therefore testing for IgG class autoantibodies is 
recommended if celiac disease is suspected. Antibodies to tTG antigen fall once a gluten-free diet 
has begun, thus facilitating monitoring of dietary compliance. Thus, anti-tTG antibodies are highly 
sensitive marker for celiac disease with 95- 100 % sensitivty, and specificity of 90 to 97 %. 
Keywords: Diabetes mellitus type I; Celiac disease and diabetes mellitus type I association; IgG 
anti-tissue transglutaminase antibodies; IgA anti-endomysial antibodies  
 
luten-sensitive enteropathy or celiac 
disease (CD) is a common cause of 
chronic malabsorption in children and    
 is characterized by mucosal damage of the 
possibly oats. An association between DM 
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type 1 and CD has been previously reported2.
1.3 to 12% of children with DM type may 
suffer from CD all over the world and may 
contain a high proportion of clinically 
asymptomatic and atypical cases3,4. The 
reduced prevalence of type 1 DM after gluten 
deprivation in patients with celiac disease5
and the reduced incidence of autoimmune 
diabetes in the non-obese diabetic mouse 
receiving a gluten-free diet6 are some of the 
evidence supporting the association. 
G
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Both CD and type 1DM are associated with 
the major antigen DQ2 encoded by the alleles 
DQA1*501 and DQB1*201, thus providing a 
common genetic basis for expression of both 
diseases7. However in DM type 1 the genetic 
association has been found to be linked to 
DR3 and/or HLA DR4 loci. The high 
prevalence of CD in DM type 1 patients 
warrants routine screening of this group2.
The diagnosis of CD was dependent on either 
detection of IgA anti-endomysial antibodies 
or endoscopic biopsy.  Since 2-3% of patient 
with CD have selective IgA deficiency8, it 
would be difficult to diagnose the CD among 
patients with DM type I. In Sudan diagnosis 
of celiac disease depends on biopsy from 
small bowel (invasive method) or detection of 
anti-endomysial antibodies of IgA class9.
Recently new tests have been introduced. 
These tests have the capacity to detect IgG 
against the antigen tissue transglutaminase, an 
enzyme from intestine due to destruction by 
CD.  
The current study is aiming at diagnosis the 
association of Celiac disease and diabetes 
mellitus in Sudanese children by using newly 
introduced immunological methods e.g., anti-
tTG ( IgA) & ( IgG). As the sensitivity of 
anti-tTG is high, it is highly recommended for 
diagnosis of unrecognized celiac disease in 
patients with insulin-dependent diabetes 
mellitus as they may have an increased 
prevalence of celiac disease. 
 
Patients and Methods: 
Ethical considerations: The current study 
had received an ethical approval from the 
ethical committee of Al Neelain University. 
Aims of the study was clearly explained to all 
volunteers and an informed consent was 
obtained from each volunteer. The 
confidentiality of patients was established by 
coding of samples. All investigations were 
carried out free of charge and patients were 
not claimed for analysis expenses. 
Study design: case control: The study was 
conducted in 69 diabetic patients and 25 
apparently healthy subjects. A comprehensive   
history was taken guided by the data 
collection sheet for each individual. Weight 
and height were measured to the nearest 
decimals and recorded. Body mass index 
(BMI) was calculated using the formula: BMI 
(Kg/m2) = weight (Kg) / (height)2 (m2).  
Study area and population: Sixty nine 
diabetic patients attending the outpatient 
clinic at Gabir Abu Eliz diabetic center, 
which is located in Khartoum state, and from 
Omdurman pediatric emergency Hospital 
were enrolled. 
Sample processing: Five ml of whole blood 
were collected from each patient using 
acceptable medical techniques to avoid 
hemolysis and were left to clot for 2-3 hours 
at room temperature and then were 
centrifuged at 3000 rpm for 10 minutes and 
sera were stored at -20°c until used. Grouping 
of patients was made according to the WHO 
criteria10.
Measurement of fasting blood glucose 
level: Glucose level was measured 
immediately before blood clotting by using 
Trinder’s glucose oxidase method. In brief, 
glucose was essentially oxidized to gluconic 
acid and hydrogen peroxide by glucose 
oxidase. The hydrogen peroxide produced 
was reacted in the presence of peroxidase 
with 4-aminoantipyrine and 
p.hydroxybenzene sulphonate to from 
aquinonimine dye. The intensity of the color 
produced was at 505 nm. Glucose 
concentration was calculated according to the 
following formula: 
Glucose concentration of samples in mg/dl = 
 
A sample – A blank 
 ____________________________________   X concentration of standard in mg/dl 
 A sample – A blank 
 
Diagnosis of Celiac disease using 
immunological methods: Screening for CD 
was done using three methods: anti-tissue-
transglutaminase IgA, anti-tissue-
transglutaminase IgG  and anti-endomysial 
IgA. Non competitive solid phase Enzyme 
Linked Immuno-Sorbent Assay (ELISA) was 
used to detect tissue transglutaminase specific 
antibodies. 
Anti-tissue-transglutaminase IgA or IgG. 
Using serological testing, many patients with 
Celiac disease can be identified quickly once 
the diagnosis is suspected. In this study, anti 
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tTG testing was undertaken with a 
commercially obtained ELISA kit (Orgentec, 
Germany) and performed essentially as 
described in details previously11. Briefly, 
stored samples were thawed and diluted 1:100 
with sample buffer and tested in duplicate at 
room temperature along with appropriate 
negative and positive controls. is bound in 96 
high binding microtitre well plates. 
Antibodies against this  antigen, if present in 
diluted serum or plasma, bind to the human 
recombinant tissue transglutaminase 
immobilized to the bottom of wells. 
Following, plates were washed in triplicate to 
remove unspecific antibodies or plasma 
components. Then 100 �l of Horseradish 
peroxidase (HRP) conjugate anti human IgA 
or IgG immunologically were added to each 
well and incubate for 15 minutes at room 
temperature to detect the tTG specific 
antibodies in patients sera. Then plates were 
washed by wash solution in 3X to remove 
unbound conjugate. Reaction was catalyzed 
by adding 100 �l of enzyme substrate to each 
well and the plates were incubated for 15 
minutes at room temperature. The reaction 
was stopped by adding 100 �l of stop solution 
and incubated 5 minutes. Results were read 
by ELISA reader at wave length 450 nm. An 
ELISA cut-off of for anti-tissue-
transglutaminase IgA or IgG is 10 U/ml.
Measurement of endomysial specific 
antibodies: This was performed by indirect 
immunofluorescence method, using a 
commercially available kit (Orgentec, 
Germany). In brief, samples were thawed and 
diluted 1:5 with sample buffer. Following that 
50 µL from each sample were added in 
duplicate to slides coated with anti-
endomysial antibodies (AEA) bind the 
corresponding antigens present in a section of 
the lower one-third of the monkey esophagus 
on cryostat sections of monkey esophagus and 
incubated at room temperature along with 
appropriate negative and positive controls for 
15 minutes. Washing in triplicate gently was 
undertaken to avoid cross contamination of 
the sera. Then slides were rinsed gently with 
Phosphate Buffer Saline (PBS) by immersing 
in a washing tray filled with PBS for 5 
minutes and slides were allowed to get dry by 
means of the blotting paper provided. Then 50 
µL of conjugate on each well were added and 
slides were incubated for 30 minutes at room 
temperature then washed 3X and dried. 
Finally the resulting antigen-antibody 
complexes were detected by means of a 
fluorescein labeled anti-human 
immunoglobulin A, and visualized with the 
aid of a fluorescence. 
Statistical analysis: Statistical package for 
social sciences program (SPSS) and microsoft 
office excel were used for data. Screening 
studied variables for significant differences in 
the means between the groups was performed 
using the Student two-tailed, unpaired T-test. 
Cross-tabulation of diabetes mellitus against 
presence of celiac disease was performed to 
calculate the relative risk ratio for occurrence 
of celiac disease in diabetic patients. 
Association between diabetes mellitus and 
celiac disease was assessed using Chi square 
test. In all of these statistical tests, only P < 
0.05 was considered significant. 
Results:  
The study involved two groups: a test group 
of 69 diabetic patients (38 (55.1%) males and 
31 (44.9%) females) and control group of 25 
apparently healthy subjects (9 (36.0%) males 
and 14 (64.0%) females). Table-1 shows a 
comparison between the diabetic patients and 
the control group as regarding age, weight, 
height, body mass index (BMI), fasting Blood 
Sugar. Table 2 shows fasting blood sugar, 
anti-tissue transglutaminase (anti-tTG) IgA 
and IgG titers in diabetic and non diabetic. 
47.8% of the diabetic patients have history of 
recurrent diarrhea, abdominal pain and/or 
weight loss. In addition, 13% have history of 
other illnesses e.g. bronchial asthma, anemia 
and pneumonia. The mean BMI of diabetic 
patients (mean (M) ± standard deviation (SD) 
= 18.5±3.4) was significantly higher when 
compared with the non-diabetic subjects 
(M±SD = 17.1±1.9). The mean of both anti-
tTG IgA and IgG titers were higher in 
diabetic patients (M±SD = 12.30±41.0 and 
7.2±13.1 respectively) when compared with  
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the control group (M±SD =1.8±1.1 and 
1.8±0.9 respectively), However, only anti-
TTG IgG antibodies titer achieved statistical 
significance. 
Figure (1) shows results of ELISA tests when 
used for detection of celiac disease. The anti-
endomysal IgA, Anti-tTG IgA and Anti-tTG 
IgG antibodies titers were all negative for the 
control group. However, 10.1% (7 subjects) 
of the diabetic patients were diagnosed as 
having celiac disease. Two celiac disease 
patients out of the seven (28.6%) had negative 
anti-tTG and endomysal IgA antibodies titers. 
As shown in table 3 the risk of developing 
celiac disease is 3.48 times in diabetic 
children compared with the control group. 
However, cross-tabulation of diabetes 
mellitus against presence of celiac disease 
markers failed to demonstrate statistical 
significance (Pearson Chi square = 2.740, P = 
0.098). 
Discussion: 
The main objective of this study was to detect 
the association of celiac disease and diabetes 
mellitus type 1 in Sudanese children. To our 
knowledge, studies in this field are extremely 
rare in Sudan. Results were interesting and 
showed that more than 10% of the studied 
diabetic patients were suffering from celiac 
disease. The frequency of celiac disease in the 
population studied was approximately 
compared with studies conducted in Kuwait12 












Interval  of the 
Difference 
Lower Upper 
Age (year) 9.8±2.9 11.7±4.0 0.014 -3.46 -0.41 
Weight (Kg) 32.9±5.7 36.9±11.3 0.101 -8.64 0.78 
Height (Cm) 138.2±5.7 139.9±19.8 0.677 -9.70 6.32 
BMI (Kg/M2) 17.1±1.9 18.5±3.4 0.048 -2.83 -0.01 
Table 2: Comparison between the diabetic patients and the control group:  













 Interval of the 
Difference 
Lower Upper 
Fasting Blood Sugar (mg/dl) 88.9±9.3 244.6±103.7 0.000 -197.07 -114.27 
Anti-tTG  IgA Titer 1.8±1.1 12.30±41.0 0.205 -26.82 5.83 
Anti-tTG IgG Titer 1.8±0.9 7.2±13.1 0.043 -10.59 -0.16 
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Table 3 Diabetes mellitus versus celiac disease cross-tabulation 
 Diabetes Mellitus Total 
Positive Negative 
Celiac Disease 
Positive 7 0 7 
Negative 62 25 87 
Total 69 25 94 
Pearson Chi square  = 2.740  
P = 0.098 
Relative Risk = 3.48 
 
Figure (1): Celiac disease detection by anti-endomysal IgA, anti-tTG IgA  and anti-tTG IgG 
antibodies in studied subjects
 
and Saudia Arabia13. The risk of developing 
celiac disease is 3.48 times in diabetic 
children compared with the control group. 
This increased association of CD and DM 
type 1 is most probably due to a common 
genetic predisposition as suggested by the 
increased occurrence of HLA-DR3,  DQ2 
encoded by the alleles DQA1*501 and 
DQB1*201, thus providing a common genetic 
basis for expression of both diseases7.
It is worth mentioning that most of the studied 
diabetic patients were poorly controlled 
(M±SD of fasting blood sugar = 244.6±103.7 
mg/dl) in spite of insulin therapy. In addition, 
there was significant difference in the mean 
body mass index when diabetic patients with 
celiac disease (M±SD = 20.0±4.6 Kg) were 
compared with the control group (M±SD = 
17.1±1.9 Kg) (P = 0.029). However, the mean 
body mass index of the diabetic patients with 
no celiac disease (M±SD = 18.4±3.2 Kg) was 
not significantly increased compared with 
non-diabetic control subjects (P = 0.083). 
These results are attention-grabbing because 
celiac disease is expected to reduce weight 
and consequently body mass index. An 
explanation for this high body mass index is 
co-existence of insulin resistance which is 
commonly associated with obesity. 
Nonetheless, early-onset non-insulin 
dependent diabetes mellitus i.e. insulin 
resistance is less common in pediatric 
patients. In the present study indices of 
insulin resistance were not measured and 
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remained to be explored by further studies in 
diabetic patients with celiac disease. 
In contrast to anti-tTG IgA antibodies titer, 
anti-tTG IgG antibodies titer was significantly 
higher in diabetic patients when compared 
with the control group. This proved the 
competence of anti-tTG IgG antibodies in 
detection of celiac disease in diabetic patients. 
The study by Rittmeyer and others 199614 
reported that selective IgA deficiency is 
considered a risk factor for celiac disease and 
occurring with a high frequency of 
approximately 3% in both diabetes and CD. 
This finding is further confirmed in the 
present study by the higher detection 
capability of anti-tTG IgG compared with 
both anti-tTG IgA and anti-endomysal IgA 
(table1). 
Conclusion 
The present study confirms that patients with 
insulin-dependent diabetes have an increased 
tendency to develop celiac disease and most 
cases are clinically unrecognized. 
Consideration should be given to screening all 
insulin-dependent diabetes mellitus patients 
for gluten intolerance. Screening for celiac 
disease should be part of the routine 
investigation to diagnose diabetes mellitus 
especially in children because of the high 
prevalence and the potential benefits of 
treatment with a gluten free diet. This also 
includes control of symptoms, stabilization of 
diabetes and prevention of complications 
associated with celiac disease. Thus, there 
may be considerable benefits derived from 
screening and early detection of CD. 
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